APA (7th ed.) Citation

Chuang, H., Lin, C., Huang, W., Kuo, W., Chen, W., & Hsiao, F. (2022). HPR21 Characteristics and Treatment Patterns of Tofacitinib Users in Taiwan, 2015-2019. Value in Health, 25(7), S470. https://doi.org/10.1016/j.jval.2022.04.947

Chicago Style (17th ed.) Citation

Chuang, HM, CW Lin, WI Huang, WJ Kuo, WW Chen, and FYS Hsiao. "HPR21 Characteristics and Treatment Patterns of Tofacitinib Users in Taiwan, 2015-2019." Value in Health 25, no. 7 (2022): S470. https://doi.org/10.1016/j.jval.2022.04.947.

MLA (9th ed.) Citation

Chuang, HM, et al. "HPR21 Characteristics and Treatment Patterns of Tofacitinib Users in Taiwan, 2015-2019." Value in Health, vol. 25, no. 7, 2022, p. S470, https://doi.org/10.1016/j.jval.2022.04.947.